Yahoo Finance Procter & Gamble (NYSE:PG) Misses Q2 Revenue Estimates
Consumer products behemoth Proctor & Gamble (NYSE:PG) fell short of analysts' expectations in Q2 CY2024, with revenue flat year on year at $20.53 billion. It made a non-GAAP profit of $1.40 per share, improving from its profit of $1.37 per share in the same quarter last year.
Is now the time to buy Procter & Gamble? Find out in our full research report.
Procter & Gamble (PG) Q2 CY2024 Highlights:
Revenue: $20.53 billion vs analyst estimates of $20.74 billion (small miss)
EPS (non-GAAP): $1.40 vs analyst estimates of $1.37 (1.9% beat)
Full year EPS (non-GAAP) guidance: $6.98 vs analyst estimates of $6.96 (slight beat)
Gross Margin (GAAP): 49.6%, in line with the same quarter last year
Free Cash Flow of $4.97 billion, up 51% from the previous quarter
Organic Revenue rose 2% year on year (8% in the same quarter last year) (miss vs. expectations of up 3.2%)
Sales Volumes rose 1% year on year (-1% in the same quarter last year)
Market Capitalization: $401.1 billion
“Fiscal year 2024 was another year of strong results for P&G,” said Jon Moeller, Chairman of the Board, President and Chief Executive Officer.
Founded by candle maker William Procter and soap maker James Gamble, Proctor & Gamble (NYSE:PG) is a consumer products behemoth whose product portfolio spans everything from facial tissues to laundry detergent to feminine care to men’s grooming.
Household Products
Household products stocks are generally stable investments, as many of the industry's products are essential for a comfortable and functional living space. Recently, there's been a growing emphasis on eco-friendly and sustainable offerings, reflecting the evolving consumer preferences for environmentally conscious options. These trends can be double-edged swords that benefit companies who innovate quickly to take advantage of them and hurt companies that don't invest enough to meet consumers where they want to be with regards to trends.
Sales Growth
Procter & Gamble is one of the most widely recognized consumer staples companies in the world. Its influence over consumers gives it extremely high negotiating leverage with distributors, enabling it to pick and choose where it sells its products (a luxury many don't have).
As you can see below, the company's annualized revenue growth rate of 3.4% over the last three years was sluggish as consumers bought less of its products. We'll explore what this means in the "Volume Growth" section.
This quarter, Procter & Gamble missed Wall Street's estimates and reported a rather uninspiring 0.1% year-on-year revenue decline, generating $20.53 billion in revenue. Looking ahead, Wall Street expects sales to grow 3.2% over the next 12 months, an acceleration from this quarter.
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
Volume Growth
Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.
To analyze whether Procter & Gamble generated its growth from changes in price or volume, we can compare its volume growth to its organic revenue growth, which excludes non-fundamental impacts on company financials like mergers and currency fluctuations.
Over the last two years, Procter & Gamble's average quarterly sales volumes have shrunk by 1.8%. This decrease isn't ideal as the quantity demanded for consumer staples products is typically stable. Luckily, Procter & Gamble was able to offset fewer customers purchasing its products by charging higher prices, enabling it to generate 5.4% average organic revenue growth. We hope the company can grow its volumes soon, however, as consistent price increases (on top of inflation) aren't sustainable over the long term unless the business is really really special.
In Procter & Gamble's Q2 2024, year on year sales volumes were flat. This result was a well-appreciated turnaround from the 1% year-on-year decline it posted 12 months ago, showing the company is heading in the right direction.
Key Takeaways from Procter & Gamble's Q2 Results
The company's revenue unfortunately missed analysts' expectations, driven by weaker-than-expected organic sales growth. While full year EPS guidance was in line, the market seems to be focusing on the disappointing topline results. The stock traded down 4.2% to $162.90 immediately after reporting.
So should you invest in Procter & Gamble right now? When making that decision, it's important to consider its valuation, business qualities, as well as what has happened in the latest quarter. We cover that in our actionable full research report which you can read here, it's free.
